Selank + Semax

Selank + Semax

Selank + Semax is a research blend combining two well-characterised synthetic neuropeptides of Russian origin: Selank (a heptapeptide anxiolytic derived from tuftsin) and Semax (a heptapeptide nootropic derived from ACTH(4-7)). Each peptide has an independent and extensively studied mechanism of action, and their combination is of research interest for investigating complementary or synergistic effects on anxiety, cognition, neurotrophin expression, and stress resilience. This blend is supplied as a lyophilised research compound for in vitro and preclinical investigation.

Mechanism of Action

Selank modulates GABAergic neurotransmission and reduces anxiety-related behaviour through interaction with GABA-A receptor complexes, while also upregulating BDNF expression and stabilising enkephalin degradation — contributing to anxiolytic and mood-stabilising effects. Semax acts primarily through upregulation of BDNF and NGF in the hippocampus and frontal cortex, enhancing synaptic plasticity, long-term potentiation, and dopaminergic/serotonergic neurotransmission. Together, the blend targets both the anxiolytic and cognitive-enhancing axes of neuropeptide research, making it a useful tool for studying the interplay between stress modulation and cognitive performance.

Research Applications

• Complementary anxiolytic and nootropic neuropeptide interaction studies
• BDNF and NGF co-upregulation and neurotrophin signalling research
• GABAergic modulation and anxiety behaviour modelling
• Cognitive enhancement, memory, and synaptic plasticity investigation
• Stress resilience and HPA axis modulation research

Specifications

• Molecular Formula: Peptide blend (Selank + Semax)
• Molecular Weight: Blend
• CAS Number: N/A
• Purity: ≥98%
• Form: Lyophilised powder
• Storage: -20°C
• Shelf Life: 24 months

This product is intended for legitimate laboratory and analytical research use only. Not for diagnostic, therapeutic, or consumer use.